TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept

Expert Opinion on Pharmacotherapy
T R Mikuls, L W Moreland

Abstract

There is accumulating evidence that tumour necrosis factor (TNF) plays a major role in the pathogenesis of rheumatoid arthritis (RA). Recent biotechnological advances have allowed for the development of agents that directly target TNF, a pro-inflammatory cytokine. In the last 2 years, the US FDA and the EU's Commission of the European Communities have approved two biological agents for the treatment of refractory RA, etanercept and infliximab. Etanercept is a fusion protein, composed of the Fc portion of IgG1 and the extracellular domain of the TNF receptor (p75). Infliximab is a chimeric monoclonal antibody (mAb) composed of murine variable and human constant regions. In placebo-controlled trials, both agents have proven to be effective and well-tolerated in RA patients. This review evaluates the available TNF inhibitors, summarises pertinent clinical trials and underscores differences between the two agents in terms of molecular structure, efficacy, safety data, antigenicity and pharmacokinetics.

References

Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R O WilliamsR N Maini
Dec 1, 1992·Current Opinion in Immunology·F M Brennan, M Feldmann
Jan 1, 1990·Advances in Experimental Medicine and Biology·H C Nauts, J R McLaren
Apr 1, 1993·Arthritis and Rheumatism·P Roux-LombardJ M Dayer
Dec 1, 1995·Annals of the Rheumatic Diseases·P Emery, M Salmon
Feb 7, 1998·Annals of Internal Medicine·W J Koopman, L W Moreland
Oct 16, 1999·Annals of Internal Medicine·P H BrionK C Kalunian
Feb 29, 2000·Arthritis and Rheumatism·T R Mikuls, J O'Dell
Jul 5, 2005·Expert Opinion on Investigational Drugs·L W Moreland

❮ Previous
Next ❯

Citations

Jul 28, 2001·The New England Journal of Medicine·R D Granstein
Aug 24, 2005·Antioxidants & Redox Signaling·Tohogo NonakaChiaki Hamanishi
Aug 24, 2006·Expert Opinion on Pharmacotherapy·Bart J F van den BemtRob Janknegt
Mar 22, 2007·Journal of Enzyme Inhibition and Medicinal Chemistry·P Singh, B K Sharma
Jan 15, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·V SchleyerR-M Szeimies
Nov 1, 2006·Reumatología clinica·Francisco Medina Rodríguez
Dec 26, 2006·Bioorganic & Medicinal Chemistry Letters·James E SheppeckJames J-W Duan
Jun 1, 2015·Naunyn-Schmiedeberg's Archives of Pharmacology·Adel M A AssiriAli H Amin
May 25, 2004·Expert Opinion on Pharmacotherapy·Shikha Nanda, Joan M Bathon
May 6, 2016·Frontiers in Immunology·Kamar-Sulu N AtretkhanyMarina S Drutskaya
Jun 30, 2016·Vascular Pharmacology·Shaomin QianCheikh I Seye
Aug 18, 2012·Journal of Medicinal Chemistry·Kathrin E MartzStefan A Laufer
Apr 18, 2002·Bioorganic & Medicinal Chemistry Letters·Toshiaki MatsuiMasaaki Toda
Oct 14, 2003·Bioorganic & Medicinal Chemistry Letters·Jie-Fei ChengAlex Nadzan
Sep 30, 2004·Bioorganic & Medicinal Chemistry Letters·Dearg S BrownStuart L Wells
Apr 28, 2004·Bioorganic & Medicinal Chemistry Letters·Jie-Fei ChengAlex M Nadzan
Sep 4, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Lena BrånénStefan Jovinge
Dec 25, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·J LundqvistB Jönsson
Sep 22, 2005·British Medical Bulletin·Christopher J Edwards
Sep 30, 2010·Nature Reviews. Rheumatology·Tsutomu Takeuchi, Hideto Kameda
Jul 3, 2019·Journal of Clinical Medicine·Birgit M KöhlerHanns-Martin Lorenz
Mar 23, 2002·Paediatric Drugs·Justine R Smith
Sep 28, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roger NewMichael Burnet
Dec 26, 2006·Bioorganic & Medicinal Chemistry Letters·James E SheppeckJames J-W Duan
Oct 4, 2002·Journal of Medicinal Chemistry·Stefan A LauferGerd K Wagner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Grainne MurphySinead Harney
Expert Opinion on Biological Therapy
Allen P Anandarajah, Christopher T Ritchlin
Best Practice & Research. Clinical Rheumatology
Joanne E Homik, Maria Suarez-Almazor
© 2021 Meta ULC. All rights reserved